Global excipients market predicted to grow at CAGR of six percent
Posted: 11 June 2020 | Victoria Rees (European Pharmaceutical Review) | No comments yet
New research has shown that the global pharmaceutical excipients market is expected to grow from $6,496.05 million in 2018 to $9,847.12 million in 2025.
According to new research, the global pharmaceutical excipients market is expected to grow from $6,496.05 million in 2018 to $9,847.12 million by the end of 2025.
Reportlinker, which conducted the research, found that this market is set to grow at a compound annual growth rate (CAGR) of 6.12 percent.
The report highlights that some of the main players in this market include Ashland Global Specialty Chemicals Inc., BASF, Evonik Industries, Roquette, The Dow Chemical Company, Archer Daniels Midland, Associated British Foods, Kerry Group and Lubrizol Chemical Company.
The researchers say that during the forecast period, the companies can enhance their growth through successive merger and acquisition (M&A) strategies, geography expansion, R&D and new product introduction strategies to execute further business expansion and growth.
The report also notes that the excipients market can be split into binders and fillers, coating agents, disintegrants, flavouring agents and colourants, lubricants and glidants, preservatives and antioxidants and sweeteners.
The report covers two proprietary models, the FPNV Positioning Matrix, which analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market, and Competitive Strategic Window, which analyses the competitive landscape in terms of markets, applications and geographies.
